Hemic and Lymphatic Diseases: News and Research on Leukocyte Disorders

MeSH tree: C15.378.553

Common antibiotic linked to possible higher death risk

Cefepime is a fourth-generation antibiotic widely used to treat serious bacterial infections and febrile neutropenia—a fever in patients with abnormally low white blood cell counts. Unlike many antibiotics that are falling ...

Study reveals a distinct subtype of eosinophilic esophagitis

Researchers from Ann & Robert H. Lurie Children's Hospital of Chicago identified a distinct subtype of eosinophilic esophagitis (EoE)—a chronic allergic inflammatory disorder in which the esophagus narrows, interfering with ...

Serious infection risks linked to targeted cancer therapies

A major real-world study by University of California, Irvine pharmacy researchers has found serious blood-related side effects associated with antibody-drug conjugates, an increasingly important class of targeted cancer therapies. ...

FDA approves Inqovi for acute myeloid leukemia

The U.S. Food and Drug Administration has approved Taiho Oncology's Inqovi (decitabine and cedazuridine) plus venetoclax for the treatment of adults with newly diagnosed acute myeloid leukemia (AML) who are 75 years or older ...

page 1 from 11